The current coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome-coronavirus 2 (SARS-CoV-2) infection, raises important questions as to whether …

Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), has become a real pandemic. After a median incubation period of 5 days …

Inhaled corticosteroids (ICS) could increase both the risk of coronavirus disease 2019
(COVID-19) and experiencing poor outcomes. To compare the clinical outcomes between …

The potential detrimental effects of steroids on the immune system to fight viral infections
had always been a concern for patients on long term steroids in chronic conditions. A recent …

Background Inhaled corticosteroids are well established for the long‐term treatment of
inflammatory respiratory diseases such as asthma or chronic obstructive pulmonary disease …

Objective: To review available evidence on corticosteroids in acute respiratory distress
syndrome (ARDS), Coronavirus Disease 2019 (COVID-19), and other viral pneumonias …

BACKGROUND: Very little direct evidence exists on use of corticosteroids in patients with
coronavirus disease 2019 (COVID-19). Indirect evidence from related conditions must …

Background: Corticosteroid treatment is an effective and common therapeutic strategy for
various inflammatory lung pathologies and may be an effective treatment for coronavirus …

Background Since its appearance in late 2019, infections caused by severe acute
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …

Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …